Tag: Motilin agonist

While gastroparesis is not common, affecting about 40 in 100,000 women and 10 in 100,000 men, its symptoms are far more widespread. For some patients, the answer to the question, **is erythromycin a prokinetic?**, offers a significant therapeutic option.

Originally used as an antibiotic, azithromycin has been investigated for its prokinetic properties in treating gastroparesis, a condition affecting stomach emptying. The off-label use of azithromycin works by mimicking a natural gut hormone to stimulate muscle contractions and accelerate the movement of food.

Over 20% of patients taking erythromycin experience some form of gastrointestinal (GI) side effect. Understanding **what is the most common adverse effect of erythromycin** is crucial for anyone prescribed this antibiotic, as mild to moderate GI distress is a frequent occurrence.

In up to 20% of emergency endoscopies for upper gastrointestinal bleeding, the source isn't found, often due to poor visualization. This raises a critical question: **is erythromycin used for GI scope** procedures to improve these outcomes? The answer is a definitive yes.

Initially discovered as an antibiotic, erythromycin is most commonly known today for its prokinetic effects, acting as a potent stimulant for the gastrointestinal (GI) tract. This makes it a key medication for improving gastric emptying in patients with conditions such as gastroparesis.